oVRcome
Adam Hutchinson, oVRcome founder and CEO, discusses reducing phobias using VR exposure therapy, how the company fills the gap in VR psychiatric care access for providers and patients, and its trial on combatting social anxiety with VR.
The program will focus on decreasing the rate of canceled medical appointments by autistic individuals using oVRcome's VR-based exposure therapy platform.
The company also announced a partnership with managed care organization CareSource to study the benefits of using virtual reality with patients receiving home and community-based services.
The VR app has been shown to reduce 75% of phobia symptoms after six weeks of treatment.